Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 16.98 -0.86 (4.82%)
Previous Close $17.84    52 Week High $30.40 
Open $17.85    52 Week Low $11.86 
Day High $18.11    P/E N/A 
Day Low $16.93    EPS $0.00 
Volume 392,671